MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1186/s12904-023-01126-3

Медицинская библиотека · BMC palliative care · 2023

Lidocaine transdermal patches reduced pain intensity in neuropathic cancer patients already receiving opioid treatment.

Tsai Jui-Hung, Liu I-Ting, Su Pei-Fang, Huang Ying-Tzu, Chiu Ge-Lin, Chen Yu-Yeh, Lai Wei-Shu, Lin Peng-Chan

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Limited efficacy has been observed when using opioids to treat neuropathic pain. Lidocaine patches reduce neuropathic pain in postherpetic neuralgia, but their benefits for cancer-related neuropathic pain remain unclear. This study aimed to investigate a treatment for cancer-related neuropathic pain.

METHODS

We conducted a prospective, open-label, single-arm study to assess the efficacy and safety of lidocaine transdermal patches in patients experiencing localized, superficial, neuropathic cancer pain. Terminal cancer patients already receiving opioid treatment participated in the 3-day study. The primary endpoint was pain intensity evaluated by the numerical rating scale (NRS). The secondary endpoints were the pain relief score and the quality of analgesic treatment.

RESULTS

The results showed a significant difference in the median NRS over 3 days (Kruskal-Wallis test, p < 0.0001). The median NRS pain intensity from Day 1 to Day 3 was 4.0 with 95% C.I. (3.3, 5.0), 3.0 (2.5, 3.5), and 2.6 (2.0, 3.0), respectively. The difference between the median NRS pain intensities of any 2 days was significant (Wilcoxon signed-rank test, p < 0.0001). The generalized estimating equation (GEE) estimation model showed significant differences between the NRS pain intensities on any 2 days. There was no significant difference in the pain relief score or the quality of analgesic treatment.

CONCLUSIONS

In this study, the 5% lidocaine transdermal patch reduced the NRS pain intensity in neuropathic cancer patients already receiving opioid treatment. Treatment of localized and superficial neuropathic pain caused by cancer was well tolerated and effective.

Для цитирования: Tsai Jui-Hung, Liu I-Ting, Su Pei-Fang, Huang Ying-Tzu, Chiu Ge-Lin, Chen Yu-Yeh, Lai Wei-Shu, Lin Peng-Chan. Lidocaine transdermal patches reduced pain intensity in neuropathic cancer patients already receiving opioid treatment.. BMC palliative care. 2023. DOI: 10.1186/s12904-023-01126-3.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.